Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 009115
Company: NOVARTIS

Products on NDA 009115

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
SERPASIL	RESERPINE	0.1MG	TABLET;ORAL	Discontinued	None	No	No
SERPASIL	RESERPINE	0.25MG	TABLET;ORAL	Discontinued	None	No	No
SERPASIL	RESERPINE	1MG	TABLET;ORAL	Discontinued	None	No	No
SERPASIL	RESERPINE	0.2MG/4ML	ELIXIR;ORAL	Discontinued	None	No	No

Approval Date(s) and History, Letters, Labels, Reviews for NDA 009115

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
08/12/1955	ORIG-1	Approval	Type 2 - New Active Ingredient	PRIORITY		Label is not available on this site.